Kate Adamala's team at the University of Minnesota reports the first cell, built from purified molecules, that runs its own life cycle.
A University of Minnesota team led by synthetic biologist Kate Adamala has reported the first cell, assembled entirely from purified, off-the-shelf molecules, that can feed itself, grow, and split into daughter cells through its own genetic activity. The result, posted this month as a preprint on bioRxiv, is a chemistry-defined life cycle that no prior synthetic cell has run on its own.
The team's working name for the construct is the "spud cell," a nod to the stripped-down, building-block nature of its parts. What matters is the autonomous cycle: a cell made from the shelf that runs its own metabolism, copies its own genome, and divides, without a host chassis and without a stripped natural genome filling in for it.
That is the delta from the field's previous markers. The University of Minnesota's release calls it the "world's first synthetic cell that completes a full life cycle." Quanta's coverage describes a system that grows and divides on its own. Earlier synthetic cells, including the JCVI minimal-genome work, ran a borrowed bacterial genome inside a surrogate host. They were not built from scratch, and they did not run their own life cycle from purified parts. That mechanism delta — chemically defined, built from non-living starting materials, and running a full genome-driven life cycle on its own — not a generic "first synthetic cell" claim, is what this paper actually establishes.
It is still a proof of concept, not a platform. There is no claim here of a cell that competes with a bacterium, escapes a dish, or feeds an industry. In her Eye on A.I. appearance, Adamala calls the work biology's "Sputnik moment," meaning less a finished product than proof that lifelike systems can be engineered from the ground up rather than evolved.
What makes that horizon interesting is the constructive one. Adamala argues, in the same interview, that life has no "magic ingredient" and that the universe is predisposed to produce it. If she is right, the same chemically defined assembly that ran this life cycle could, in principle, be retuned to manufacture fuels, medicines, and materials without petrochemical feedstocks. A commercial actor, Biotic, already hosts a SpudCell research page pointing at the same architecture. The horizon is long. The starting point is now on the record.
The same scientist has also been on the other side of the biosecurity line. In December 2024, Adamala joined more than 30 colleagues in a perspective in Science calling for a pause on "mirror life" research: cells built from D-chirality, mirror-image molecules that the natural world does not make. Because every immune system on Earth evolved to recognize L-chirality biochemistry, the standard left-handed molecular handedness of life, a mirror microbe would, in principle, be invisible to every defense a plant, animal, or human has. The Guardian reported the call as scientists warning of an "unprecedented risk to life on Earth." Adamala's own thread on X laid out the same reasoning.
The spud cell is not mirror life. It uses standard L-chirality biochemistry and sits on the safe side of the line Adamala helped codify. The conflation is the most likely failure mode for this story, and it is worth marking: the milestone and the biosecurity red line are distinct, and reporting them as a single fact would be wrong.
The harder, more honest question is whether the spud cell is "alive" by any working definition. NASA's working definition of life, Adamala notes, does not cleanly cover a cell built from the shelf that grows and divides through its own genome. The field is now producing systems that sit on the edge of its categories, and the categories are showing it.
What comes next is peer review and independent reproduction in another lab. The work is on the record. The classification is still open.